ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0019336,phenol-containing compound catabolic process,3/157,12/18888,0.000117313141708928,0.107381233012351,0.0992187845557213,FAH/MAOB/PDE1B,3
GO:0048934,peripheral nervous system neuron differentiation,3/157,15/18888,0.00023821673030493,0.107381233012351,0.0992187845557213,HOXD9/NEFH/ONECUT2,3
GO:0048935,peripheral nervous system neuron development,3/157,15/18888,0.00023821673030493,0.107381233012351,0.0992187845557213,HOXD9/NEFH/ONECUT2,3
GO:0050804,modulation of chemical synaptic transmission,13/157,493/18888,0.000248631522259216,0.107381233012351,0.0992187845557213,ADGRB1/ADRA2A/CALB2/EGR2/NEFH/NLGN4X/NOG/RIMS1/SLC1A3/SNAP25/SNCAIP/SYBU/TACR2,13
GO:0099177,regulation of trans-synaptic signaling,13/157,494/18888,0.000253540500710808,0.107381233012351,0.0992187845557213,ADGRB1/ADRA2A/CALB2/EGR2/NEFH/NLGN4X/NOG/RIMS1/SLC1A3/SNAP25/SNCAIP/SYBU/TACR2,13
GO:0002385,mucosal immune response,4/157,38/18888,0.000272122729554515,0.107381233012351,0.0992187845557213,H2BC4/H2BC8/NOS2/PIGR,4
GO:0090083,regulation of inclusion body assembly,3/157,17/18888,0.000351694871862806,0.107381233012351,0.0992187845557213,CLU/HSPA2/SNCAIP,3
GO:0018958,phenol-containing compound metabolic process,6/157,113/18888,0.000364195135069716,0.107381233012351,0.0992187845557213,CPQ/DIO2/FAH/MAOB/PDE1B/SNCAIP,6
GO:0002251,organ or tissue specific immune response,4/157,42/18888,0.00040212857195963,0.107381233012351,0.0992187845557213,H2BC4/H2BC8/NOS2/PIGR,4
GO:0060348,bone development,8/157,215/18888,0.000443357692041088,0.107381233012351,0.0992187845557213,BMPR1B/CBS/CLDN18/GPR68/HSD17B1/NSD2/RUNX2/TULP3,8
GO:0010721,negative regulation of cell development,9/157,288/18888,0.000696254726974654,0.137880837311315,0.12740000005383,CEBPA/CLDN18/FRZB/GPR68/NOG/PIK3R1/SEMA4A/SEMA6D/SFRP1,9
GO:0023061,signal release,12/157,487/18888,0.000783710640423255,0.137880837311315,0.12740000005383,ADRA2A/GPR68/MAOB/NOS2/POMC/RIMS1/SFRP1/SNAP25/SNCAIP/SV2A/SYBU/TACR2,12
GO:0007422,peripheral nervous system development,5/157,90/18888,0.000926821403358949,0.137880837311315,0.12740000005383,ADGRB1/EGR2/HOXD9/NEFH/ONECUT2,5
GO:0009953,dorsal/ventral pattern formation,5/157,90/18888,0.000926821403358949,0.137880837311315,0.12740000005383,BMPR1B/GREM2/NOG/SFRP1/TULP3,5
GO:1901606,alpha-amino acid catabolic process,5/157,90/18888,0.000926821403358949,0.137880837311315,0.12740000005383,ASRGL1/CBS/FAH/HAAO/NOS2,5
GO:0070841,inclusion body assembly,3/157,24/18888,0.00100308171380614,0.137880837311315,0.12740000005383,CLU/HSPA2/SNCAIP,3
GO:0002762,negative regulation of myeloid leukocyte differentiation,4/157,54/18888,0.0010517482526151,0.137880837311315,0.12740000005383,CLDN18/GPR68/PIK3R1/SFRP1,4
GO:0014033,neural crest cell differentiation,5/157,93/18888,0.00107438634072611,0.137880837311315,0.12740000005383,FRZB/NRTN/SEMA4A/SEMA6D/SFRP1,5
GO:0008045,motor neuron axon guidance,3/157,26/18888,0.00127295668175175,0.137880837311315,0.12740000005383,ALCAM/EGR2/NOG,3
GO:0009065,glutamine family amino acid catabolic process,3/157,26/18888,0.00127295668175175,0.137880837311315,0.12740000005383,ASRGL1/FAH/NOS2,3
GO:0060740,prostate gland epithelium morphogenesis,3/157,26/18888,0.00127295668175175,0.137880837311315,0.12740000005383,CYP7B1/NOG/SFRP1,3
GO:0170040,proteinogenic amino acid catabolic process,4/157,57/18888,0.0012886031239119,0.137880837311315,0.12740000005383,ASRGL1/CBS/FAH/NOS2,4
GO:0046883,regulation of hormone secretion,8/157,254/18888,0.00130935559791918,0.137880837311315,0.12740000005383,ADRA2A/GPR68/NOS2/POMC/SFRP1/SNAP25/SYBU/TACR2,8
GO:0002227,innate immune response in mucosa,3/157,27/18888,0.00142339329080574,0.143644106263812,0.132725181414605,H2BC4/H2BC8/NOS2,3
GO:0007409,axonogenesis,11/157,455/18888,0.00150595394928096,0.14589681860634,0.134806656680898,ADGRB1/ALCAM/BMPR1B/EGR2/LIMK1/NEFH/NOG/OLFM1/SEMA4A/SEMA6D/SNAP25,11
GO:0060512,prostate gland morphogenesis,3/157,28/18888,0.00158453824903801,0.147605832275771,0.136385761840275,CYP7B1/NOG/SFRP1,3
GO:0170035,L-amino acid catabolic process,4/157,61/18888,0.0016592525807038,0.14884110186906,0.137527133979582,ASRGL1/CBS/FAH/NOS2,4
GO:0009063,amino acid catabolic process,5/157,111/18888,0.00235168669729565,0.187771524403353,0.173498309740331,ASRGL1/CBS/FAH/HAAO/NOS2,5
GO:0045671,negative regulation of osteoclast differentiation,3/157,33/18888,0.00256004471183394,0.187771524403353,0.173498309740331,CLDN18/PIK3R1/SFRP1,3
GO:0050796,regulation of insulin secretion,6/157,167/18888,0.00275080345340739,0.187771524403353,0.173498309740331,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU,6
GO:0035567,non-canonical Wnt signaling pathway,4/157,71/18888,0.00289764422532725,0.187771524403353,0.173498309740331,FRZB/FZD10/PLEKHA4/SFRP1,4
GO:0045670,regulation of osteoclast differentiation,4/157,71/18888,0.00289764422532725,0.187771524403353,0.173498309740331,CLDN18/GPR68/PIK3R1/SFRP1,4
GO:0006527,arginine catabolic process,2/157,10/18888,0.00295712314854897,0.187771524403353,0.173498309740331,FAH/NOS2,2
GO:0019614,catechol-containing compound catabolic process,2/157,10/18888,0.00295712314854897,0.187771524403353,0.173498309740331,MAOB/PDE1B,2
GO:0042420,dopamine catabolic process,2/157,10/18888,0.00295712314854897,0.187771524403353,0.173498309740331,MAOB/PDE1B,2
GO:0042424,catecholamine catabolic process,2/157,10/18888,0.00295712314854897,0.187771524403353,0.173498309740331,MAOB/PDE1B,2
GO:2000271,positive regulation of fibroblast apoptotic process,2/157,10/18888,0.00295712314854897,0.187771524403353,0.173498309740331,PRDM11/SFRP1,2
GO:0061035,regulation of cartilage development,4/157,72/18888,0.00304853063146408,0.187771524403353,0.173498309740331,BMPR1B/FRZB/NOG/RUNX2,4
GO:0048705,skeletal system morphogenesis,7/157,229/18888,0.00308275954303462,0.187771524403353,0.173498309740331,BMPR1B/CBS/HOXD9/NOG/RUNX2/SFRP1/TULP3,7
GO:0048675,axon extension,5/157,119/18888,0.00317862613564718,0.187771524403353,0.173498309740331,ALCAM/LIMK1/OLFM1/SEMA4A/SEMA6D,5
GO:1903707,negative regulation of hemopoiesis,5/157,119/18888,0.00317862613564718,0.187771524403353,0.173498309740331,CEBPA/CLDN18/GPR68/PIK3R1/SFRP1,5
GO:0006703,estrogen biosynthetic process,2/157,11/18888,0.00359458947788423,0.195618224531001,0.18074855289361,HSD17B1/HSD17B2,2
GO:2001204,regulation of osteoclast development,2/157,11/18888,0.00359458947788423,0.195618224531001,0.18074855289361,CLDN18/GPR68,2
GO:0050806,positive regulation of synaptic transmission,6/157,177/18888,0.00366403239216987,0.195618224531001,0.18074855289361,CALB2/NOG/RIMS1/SLC1A3/SNAP25/TACR2,6
GO:1990138,neuron projection extension,6/157,177/18888,0.00366403239216987,0.195618224531001,0.18074855289361,ALCAM/LIMK1/OLFM1/RIMS1/SEMA4A/SEMA6D,6
GO:0048846,axon extension involved in axon guidance,3/157,38/18888,0.00384016556131058,0.195618224531001,0.18074855289361,ALCAM/SEMA4A/SEMA6D,3
GO:1902284,neuron projection extension involved in neuron projection guidance,3/157,38/18888,0.00384016556131058,0.195618224531001,0.18074855289361,ALCAM/SEMA4A/SEMA6D,3
GO:0002573,myeloid leukocyte differentiation,7/157,239/18888,0.00389813713092121,0.195618224531001,0.18074855289361,CEBPA/CLDN18/GPR68/IL1RL1/PDE1B/PIK3R1/SFRP1,7
GO:0030072,peptide hormone secretion,7/157,242/18888,0.00417207623236977,0.195618224531001,0.18074855289361,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU/TACR2,7
GO:0060560,developmental growth involved in morphogenesis,7/157,243/18888,0.00426655679612307,0.195618224531001,0.18074855289361,ALCAM/LIMK1/OLFM1/RIMS1/SEMA4A/SEMA6D/SFRP1,7
GO:0000727,double-strand break repair via break-induced replication,2/157,12/18888,0.0042900447451193,0.195618224531001,0.18074855289361,GINS2/MCM4,2
GO:0002638,negative regulation of immunoglobulin production,2/157,12/18888,0.0042900447451193,0.195618224531001,0.18074855289361,CD22/IL13RA2,2
GO:1902043,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,2/157,12/18888,0.0042900447451193,0.195618224531001,0.18074855289361,BMPR1B/SFRP1,2
GO:0040001,establishment of mitotic spindle localization,3/157,40/18888,0.00444338228770057,0.195618224531001,0.18074855289361,ESPL1/GPSM2/PKHD1,3
GO:0046879,hormone secretion,8/157,311/18888,0.00454960835689003,0.195618224531001,0.18074855289361,ADRA2A/GPR68/NOS2/POMC/SFRP1/SNAP25/SYBU/TACR2,8
GO:0002790,peptide secretion,7/157,247/18888,0.00466077833273763,0.195618224531001,0.18074855289361,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU/TACR2,7
GO:0045926,negative regulation of growth,7/157,247/18888,0.00466077833273763,0.195618224531001,0.18074855289361,FRZB/MT1F/NOG/PRDM11/SEMA4A/SEMA6D/SFRP1,7
GO:0048863,stem cell differentiation,7/157,248/18888,0.00476349551154248,0.195618224531001,0.18074855289361,FRZB/NOG/NRTN/RUNX2/SEMA4A/SEMA6D/SFRP1,7
GO:0042417,dopamine metabolic process,3/157,41/18888,0.00476526641095336,0.195618224531001,0.18074855289361,MAOB/PDE1B/SNCAIP,3
GO:0008589,regulation of smoothened signaling pathway,4/157,85/18888,0.00552197824948748,0.221794523917663,0.204935094027968,RUNX2/SFRP1/TULP3/WDR11,4
GO:0009914,hormone transport,8/157,322/18888,0.00558607182451588,0.221794523917663,0.204935094027968,ADRA2A/GPR68/NOS2/POMC/SFRP1/SNAP25/SYBU/TACR2,8
GO:0090175,regulation of establishment of planar polarity,2/157,14/18888,0.00585095201819829,0.228207048185455,0.210860178383362,PKHD1/SFRP1,2
GO:0090276,regulation of peptide hormone secretion,6/157,197/18888,0.00614141045724544,0.228207048185455,0.210860178383362,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU,6
GO:2000027,regulation of animal organ morphogenesis,4/157,89/18888,0.00649125273905061,0.228207048185455,0.210860178383362,NOG/PKHD1/RUNX2/SFRP1,4
GO:0002791,regulation of peptide secretion,6/157,200/18888,0.00659784005130657,0.228207048185455,0.210860178383362,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU,6
GO:0030073,insulin secretion,6/157,200/18888,0.00659784005130657,0.228207048185455,0.210860178383362,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU,6
GO:0060026,convergent extension,2/157,15/18888,0.00671444975479728,0.228207048185455,0.210860178383362,FRZB/SFRP1,2
GO:1901160,primary amino compound metabolic process,2/157,15/18888,0.00671444975479728,0.228207048185455,0.210860178383362,MAOB/PDE1B,2
GO:2000052,positive regulation of non-canonical Wnt signaling pathway,2/157,15/18888,0.00671444975479728,0.228207048185455,0.210860178383362,PLEKHA4/SFRP1,2
GO:0090087,regulation of peptide transport,6/157,202/18888,0.00691551416755285,0.228207048185455,0.210860178383362,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU,6
GO:0007269,neurotransmitter secretion,5/157,144/18888,0.00710027508976279,0.228207048185455,0.210860178383362,RIMS1/SNAP25/SNCAIP/SV2A/TACR2,5
GO:0099643,signal release from synapse,5/157,144/18888,0.00710027508976279,0.228207048185455,0.210860178383362,RIMS1/SNAP25/SNCAIP/SV2A/TACR2,5
GO:0030516,regulation of axon extension,4/157,92/18888,0.0072879935958208,0.228207048185455,0.210860178383362,LIMK1/OLFM1/SEMA4A/SEMA6D,4
GO:0048762,mesenchymal cell differentiation,7/157,269/18888,0.00734029971902509,0.228207048185455,0.210860178383362,FRZB/NOG/NRTN/OLFM1/SEMA4A/SEMA6D/SFRP1,7
GO:0050708,regulation of protein secretion,7/157,269/18888,0.00734029971902509,0.228207048185455,0.210860178383362,ADRA2A/GPR68/MYOM1/NOS2/SFRP1/SNAP25/SYBU,7
GO:0007224,smoothened signaling pathway,5/157,146/18888,0.00751522095167814,0.228207048185455,0.210860178383362,NOG/RUNX2/SFRP1/TULP3/WDR11,5
GO:0006836,neurotransmitter transport,6/157,206/18888,0.00758393171174375,0.228207048185455,0.210860178383362,RIMS1/SLC1A3/SNAP25/SNCAIP/SV2A/TACR2,6
GO:0015833,peptide transport,7/157,271/18888,0.00763075961899175,0.228207048185455,0.210860178383362,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU/TACR2,7
GO:0007158,neuron cell-cell adhesion,2/157,16/18888,0.00763202762304783,0.228207048185455,0.210860178383362,NCAM2/NLGN4X,2
GO:0009074,aromatic amino acid family catabolic process,2/157,16/18888,0.00763202762304783,0.228207048185455,0.210860178383362,FAH/HAAO,2
GO:2000095,"regulation of Wnt signaling pathway, planar cell polarity pathway",2/157,16/18888,0.00763202762304783,0.228207048185455,0.210860178383362,PLEKHA4/SFRP1,2
GO:0030850,prostate gland development,3/157,49/18888,0.0078476155679985,0.229170216486662,0.211750132665758,CYP7B1/NOG/SFRP1,3
GO:0048704,embryonic skeletal system morphogenesis,4/157,94/18888,0.00785347975573614,0.229170216486662,0.211750132665758,HOXD9/NOG/RUNX2/TULP3,4
GO:1900120,regulation of receptor binding,2/157,17/18888,0.00860273865653916,0.243880767143487,0.225342479441546,GREM2/NOG,2
GO:1902969,mitotic DNA replication,2/157,17/18888,0.00860273865653916,0.243880767143487,0.225342479441546,BRCA2/MCM4,2
GO:0045638,negative regulation of myeloid cell differentiation,4/157,97/18888,0.00875459439803056,0.243880767143487,0.225342479441546,CLDN18/GPR68/PIK3R1/SFRP1,4
GO:0010043,response to zinc ion,3/157,51/18888,0.00876405985552951,0.243880767143487,0.225342479441546,DDX19A/HAAO/MT1F,3
GO:1903531,negative regulation of secretion by cell,5/157,152/18888,0.00886106833551893,0.243880767143487,0.225342479441546,ADRA2A/IL13RA2/MAOB/SFRP1/TACR2,5
GO:0006576,biogenic amine metabolic process,4/157,98/18888,0.00906933849858198,0.244905281472183,0.226289116610831,HAAO/MAOB/PDE1B/SNCAIP,4
GO:0007612,learning,5/157,153/18888,0.00910052656172438,0.244905281472183,0.226289116610831,NLGN4X/NOG/PDE1B/SNAP25/TACR2,5
GO:0048167,regulation of synaptic plasticity,6/157,216/18888,0.00945752190196465,0.245403355553077,0.226749330221149,ADGRB1/CALB2/EGR2/NOG/RIMS1/SNAP25,6
GO:0016082,synaptic vesicle priming,2/157,18/18888,0.00962564771987709,0.245403355553077,0.226749330221149,SNAP25/SV2A,2
GO:0036035,osteoclast development,2/157,18/18888,0.00962564771987709,0.245403355553077,0.226749330221149,CLDN18/GPR68,2
GO:0046851,negative regulation of bone remodeling,2/157,18/18888,0.00962564771987709,0.245403355553077,0.226749330221149,CLDN18/SFRP1,2
GO:0098751,bone cell development,2/157,18/18888,0.00962564771987709,0.245403355553077,0.226749330221149,CLDN18/GPR68,2
GO:0045667,regulation of osteoblast differentiation,5/157,156/18888,0.00984565662311848,0.248397711887427,0.229516074350328,BMPR1B/CEBPA/NOG/RUNX2/SFRP1,5
GO:0007517,muscle organ development,8/157,359/18888,0.0104290838849131,0.256847863482465,0.23732389837182,ADGRB1/EGR2/HOXD9/HSD17B1/MKX/MYL3/MYOM1/NOG,8
GO:0006525,arginine metabolic process,2/157,19/18888,0.0106998313794882,0.256847863482465,0.23732389837182,FAH/NOS2,2
GO:0042402,cellular biogenic amine catabolic process,2/157,19/18888,0.0106998313794882,0.256847863482465,0.23732389837182,MAOB/PDE1B,2
GO:0006584,catecholamine metabolic process,3/157,56/18888,0.0113200549686376,0.256847863482465,0.23732389837182,MAOB/PDE1B/SNCAIP,3
GO:0009712,catechol-containing compound metabolic process,3/157,56/18888,0.0113200549686376,0.256847863482465,0.23732389837182,MAOB/PDE1B/SNCAIP,3
GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus,3/157,56/18888,0.0113200549686376,0.256847863482465,0.23732389837182,ADRA2A/GPR68/SYBU,3
GO:0051223,regulation of protein transport,9/157,440/18888,0.0114323704825313,0.256847863482465,0.23732389837182,ADRA2A/GPR68/MYOM1/NOS2/PIK3R1/SFRP1/SNAP25/SYBU/ZFAND1,9
GO:0006520,amino acid metabolic process,7/157,295/18888,0.0118139372042964,0.256847863482465,0.23732389837182,ASRGL1/CBS/FAH/HAAO/NOS2/PEPD/SLC1A3,7
GO:0032253,dense core granule localization,2/157,20/18888,0.0118243777757328,0.256847863482465,0.23732389837182,SNAP25/SYBU,2
GO:0032332,positive regulation of chondrocyte differentiation,2/157,20/18888,0.0118243777757328,0.256847863482465,0.23732389837182,BMPR1B/RUNX2,2
GO:0034755,iron ion transmembrane transport,2/157,20/18888,0.0118243777757328,0.256847863482465,0.23732389837182,MMGT1/SLC25A37,2
GO:0071391,cellular response to estrogen stimulus,2/157,20/18888,0.0118243777757328,0.256847863482465,0.23732389837182,CLDN18/SFRP1,2
GO:2000269,regulation of fibroblast apoptotic process,2/157,20/18888,0.0118243777757328,0.256847863482465,0.23732389837182,PRDM11/SFRP1,2
GO:0001755,neural crest cell migration,3/157,57/18888,0.0118773578489001,0.256847863482465,0.23732389837182,NRTN/SEMA4A/SEMA6D,3
GO:0051293,establishment of spindle localization,3/157,57/18888,0.0118773578489001,0.256847863482465,0.23732389837182,ESPL1/GPSM2/PKHD1,3
GO:1901616,organic hydroxy compound catabolic process,3/157,57/18888,0.0118773578489001,0.256847863482465,0.23732389837182,FAH/MAOB/PDE1B,3
GO:0030316,osteoclast differentiation,4/157,107/18888,0.0122377648805518,0.25884935344453,0.239173247608792,CLDN18/GPR68/PIK3R1/SFRP1,4
GO:0009306,protein secretion,8/157,370/18888,0.0123391091370449,0.25884935344453,0.239173247608792,ADRA2A/GPR68/MYOM1/NOS2/SFRP1/SNAP25/SYBU/TACR2,8
GO:0035592,establishment of protein localization to extracellular region,8/157,371/18888,0.0125246976430744,0.25884935344453,0.239173247608792,ADRA2A/GPR68/MYOM1/NOS2/SFRP1/SNAP25/SYBU/TACR2,8
GO:0006937,regulation of muscle contraction,5/157,167/18888,0.0129356431941343,0.25884935344453,0.239173247608792,ADRA2A/CLIC2/MYL3/TACR2/TMEM38A,5
GO:0006268,DNA unwinding involved in DNA replication,2/157,21/18888,0.0129983864963136,0.25884935344453,0.239173247608792,GINS2/MCM4,2
GO:0009310,amine catabolic process,2/157,21/18888,0.0129983864963136,0.25884935344453,0.239173247608792,MAOB/PDE1B,2
GO:0034104,negative regulation of tissue remodeling,2/157,21/18888,0.0129983864963136,0.25884935344453,0.239173247608792,CLDN18/SFRP1,2
GO:0048791,calcium ion-regulated exocytosis of neurotransmitter,2/157,21/18888,0.0129983864963136,0.25884935344453,0.239173247608792,RIMS1/SNAP25,2
GO:0061387,regulation of extent of cell growth,4/157,109/18888,0.0130265273875637,0.25884935344453,0.239173247608792,LIMK1/OLFM1/SEMA4A/SEMA6D,4
GO:0090497,mesenchymal cell migration,3/157,59/18888,0.0130386544674784,0.25884935344453,0.239173247608792,NRTN/SEMA4A/SEMA6D,3
GO:0030509,BMP signaling pathway,5/157,168/18888,0.0132455249960174,0.259980734358988,0.240218628035642,BMPR1B/GREM2/NOG/RUNX2/SFRP1,5
GO:0007173,epidermal growth factor receptor signaling pathway,4/157,110/18888,0.0134327866073029,0.259980734358988,0.240218628035642,ADRA2A/GRB7/PIGR/REPS2,4
GO:0007411,axon guidance,6/157,234/18888,0.0136268285344569,0.259980734358988,0.240218628035642,ALCAM/BMPR1B/EGR2/NOG/SEMA4A/SEMA6D,6
GO:0097485,neuron projection guidance,6/157,234/18888,0.0136268285344569,0.259980734358988,0.240218628035642,ALCAM/BMPR1B/EGR2/NOG/SEMA4A/SEMA6D,6
GO:0060350,endochondral bone morphogenesis,3/157,60/18888,0.0136427716830141,0.259980734358988,0.240218628035642,BMPR1B/CBS/RUNX2,3
GO:0030038,contractile actin filament bundle assembly,4/157,111/18888,0.0138470333329106,0.259980734358988,0.240218628035642,LIMK1/PHACTR1/PIK3R1/SFRP1,4
GO:0043149,stress fiber assembly,4/157,111/18888,0.0138470333329106,0.259980734358988,0.240218628035642,LIMK1/PHACTR1/PIK3R1/SFRP1,4
GO:0071692,protein localization to extracellular region,8/157,379/18888,0.014084157611013,0.26182036068791,0.241918417498586,ADRA2A/GPR68/MYOM1/NOS2/SFRP1/SNAP25/SYBU/TACR2,8
GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,2/157,22/18888,0.0142209684509691,0.26182036068791,0.241918417498586,CLIC2/TMEM38A,2
GO:1902106,negative regulation of leukocyte differentiation,4/157,112/18888,0.0142693177583832,0.26182036068791,0.241918417498586,CLDN18/GPR68/PIK3R1/SFRP1,4
GO:0048588,developmental cell growth,6/157,238/18888,0.0147038691510396,0.266812862936178,0.246531421010176,ALCAM/LIMK1/OLFM1/RIMS1/SEMA4A/SEMA6D,6
GO:0051048,negative regulation of secretion,5/157,173/18888,0.0148703122277187,0.266812862936178,0.246531421010176,ADRA2A/IL13RA2/MAOB/SFRP1/TACR2,5
GO:0051653,spindle localization,3/157,62/18888,0.0148982155269193,0.266812862936178,0.246531421010176,ESPL1/GPSM2/PKHD1,3
GO:0042445,hormone metabolic process,6/157,240/18888,0.0152640320550323,0.266812862936178,0.246531421010176,CEL/CPQ/DIO2/HSD17B1/HSD17B2/RDH16,6
GO:0006590,thyroid hormone generation,2/157,23/18888,0.0154912457474367,0.266812862936178,0.246531421010176,CPQ/DIO2,2
GO:0031290,retinal ganglion cell axon guidance,2/157,23/18888,0.0154912457474367,0.266812862936178,0.246531421010176,ALCAM/BMPR1B,2
GO:0032252,secretory granule localization,2/157,23/18888,0.0154912457474367,0.266812862936178,0.246531421010176,SNAP25/SYBU,2
GO:0006813,potassium ion transport,6/157,241/18888,0.0155496024666094,0.266812862936178,0.246531421010176,ADRA2A/KCNK12/SLC1A3/SLC9A3/SNAP25/TMEM38A,6
GO:1902905,positive regulation of supramolecular fiber organization,5/157,175/18888,0.0155560179328688,0.266812862936178,0.246531421010176,C15orf62/CLU/FCHSD2/LIMK1/SFRP1,5
GO:0042886,amide transport,7/157,312/18888,0.015643033252245,0.266812862936178,0.246531421010176,ADRA2A/GPR68/NOS2/SFRP1/SNAP25/SYBU/TACR2,7
GO:0090257,regulation of muscle system process,6/157,245/18888,0.0167289893132946,0.282285908044046,0.260828302186815,ADRA2A/CLIC2/GTF2IRD1/MYL3/TACR2/TMEM38A,6
GO:0042430,indole-containing compound metabolic process,2/157,24/18888,0.0168083515686758,0.282285908044046,0.260828302186815,HAAO/PDE1B,2
GO:0009308,amine metabolic process,4/157,118/18888,0.016974479983376,0.282285908044046,0.260828302186815,HAAO/MAOB/PDE1B/SNCAIP,4
GO:0071772,response to BMP,5/157,180/18888,0.0173619760250966,0.282285908044046,0.260828302186815,BMPR1B/GREM2/NOG/RUNX2/SFRP1,5
GO:0071773,cellular response to BMP stimulus,5/157,180/18888,0.0173619760250966,0.282285908044046,0.260828302186815,BMPR1B/GREM2/NOG/RUNX2/SFRP1,5
GO:0001655,urogenital system development,3/157,66/18888,0.0175991627228121,0.282285908044046,0.260828302186815,CYP7B1/NOG/SFRP1,3
GO:0017156,calcium-ion regulated exocytosis,3/157,66/18888,0.0175991627228121,0.282285908044046,0.260828302186815,ADRA2A/RIMS1/SNAP25,3
GO:0035773,insulin secretion involved in cellular response to glucose stimulus,3/157,66/18888,0.0175991627228121,0.282285908044046,0.260828302186815,ADRA2A/GPR68/SYBU,3
GO:0042446,hormone biosynthetic process,3/157,66/18888,0.0175991627228121,0.282285908044046,0.260828302186815,DIO2/HSD17B1/HSD17B2,3
GO:1903306,negative regulation of regulated secretory pathway,2/157,25/18888,0.0181714300513378,0.288296729702289,0.266382218847871,ADRA2A/IL13RA2,2
GO:0046888,negative regulation of hormone secretion,3/157,67/18888,0.0183141966637849,0.288296729702289,0.266382218847871,ADRA2A/SFRP1/TACR2,3
GO:0051222,positive regulation of protein transport,6/157,251/18888,0.0186117413487353,0.288296729702289,0.266382218847871,GPR68/MYOM1/PIK3R1/SNAP25/SYBU/ZFAND1,6
GO:0051495,positive regulation of cytoskeleton organization,5/157,184/18888,0.018903042186308,0.288296729702289,0.266382218847871,C15orf62/FCHSD2/GPSM2/LIMK1/SFRP1,5
GO:0030278,regulation of ossification,4/157,122/18888,0.0189444441423342,0.288296729702289,0.266382218847871,BMPR1B/EGR2/RUNX2/SFRP1,4
GO:0030326,embryonic limb morphogenesis,4/157,122/18888,0.0189444441423342,0.288296729702289,0.266382218847871,HOXD9/NOG/RUNX2/TULP3,4
GO:0035113,embryonic appendage morphogenesis,4/157,122/18888,0.0189444441423342,0.288296729702289,0.266382218847871,HOXD9/NOG/RUNX2/TULP3,4
GO:0035019,somatic stem cell population maintenance,3/157,68/18888,0.0190452009712495,0.288296729702289,0.266382218847871,NOG/POU5F1/SFRP1,3
GO:0046847,filopodium assembly,3/157,68/18888,0.0190452009712495,0.288296729702289,0.266382218847871,FGD5/MIEN1/PIK3R1,3
GO:0010882,regulation of cardiac muscle contraction by calcium ion signaling,2/157,26/18888,0.01957963616547,0.290931771734775,0.268816961496862,CLIC2/TMEM38A,2
GO:0042537,benzene-containing compound metabolic process,2/157,26/18888,0.01957963616547,0.290931771734775,0.268816961496862,FAH/HAAO,2
GO:0044346,fibroblast apoptotic process,2/157,26/18888,0.01957963616547,0.290931771734775,0.268816961496862,PRDM11/SFRP1,2
GO:0008202,steroid metabolic process,7/157,329/18888,0.0202833322515399,0.299311516977469,0.276559731015733,CEBPA/CUBN/CYP7B1/HSD17B1/HSD17B2/RDH16/SULT2B1,7
GO:0001952,regulation of cell-matrix adhesion,4/157,125/18888,0.0205111606959152,0.299311516977469,0.276559731015733,ONECUT2/PIK3R1/PKHD1/SFRP1,4
GO:0042593,glucose homeostasis,6/157,258/18888,0.020986011126475,0.299311516977469,0.276559731015733,ADRA2A/CEBPA/GPR68/PIK3R1/POMC/SYBU,6
GO:0007141,male meiosis I,2/157,27/18888,0.0210321355954431,0.299311516977469,0.276559731015733,BRCA2/HSPA2,2
GO:0070193,synaptonemal complex organization,2/157,27/18888,0.0210321355954431,0.299311516977469,0.276559731015733,HSPA2/SHOC1,2
GO:2000050,regulation of non-canonical Wnt signaling pathway,2/157,27/18888,0.0210321355954431,0.299311516977469,0.276559731015733,PLEKHA4/SFRP1,2
GO:0045600,positive regulation of fat cell differentiation,3/157,71/18888,0.0213341994479028,0.299311516977469,0.276559731015733,CEBPA/FRZB/SFRP1,3
GO:0006898,receptor-mediated endocytosis,6/157,259/18888,0.0213411870898952,0.299311516977469,0.276559731015733,CLU/CUBN/FCHSD2/GRK3/SFTPD/SNAP25,6
GO:0033500,carbohydrate homeostasis,6/157,259/18888,0.0213411870898952,0.299311516977469,0.276559731015733,ADRA2A/CEBPA/GPR68/PIK3R1/POMC/SYBU,6
GO:0030308,negative regulation of cell growth,5/157,190/18888,0.0213793940698192,0.299311516977469,0.276559731015733,FRZB/PRDM11/SEMA4A/SEMA6D/SFRP1,5
GO:0030514,negative regulation of BMP signaling pathway,3/157,72/18888,0.0221292285268784,0.303128163303895,0.28008625980446,GREM2/NOG/SFRP1,3
GO:1904888,cranial skeletal system development,3/157,72/18888,0.0221292285268784,0.303128163303895,0.28008625980446,NOG/RUNX2/TULP3,3
GO:0002761,regulation of myeloid leukocyte differentiation,4/157,128/18888,0.0221554312213343,0.303128163303895,0.28008625980446,CLDN18/GPR68/PIK3R1/SFRP1,4
GO:0048706,embryonic skeletal system development,4/157,128/18888,0.0221554312213343,0.303128163303895,0.28008625980446,HOXD9/NOG/RUNX2/TULP3,4
GO:0060485,mesenchyme development,7/157,336/18888,0.0224476825518523,0.303128163303895,0.28008625980446,FRZB/NOG/NRTN/OLFM1/SEMA4A/SEMA6D/SFRP1,7
GO:0010165,response to X-ray,2/157,28/18888,0.0225281046220897,0.303128163303895,0.28008625980446,BRCA2/SFRP1,2
GO:0048843,negative regulation of axon extension involved in axon guidance,2/157,28/18888,0.0225281046220897,0.303128163303895,0.28008625980446,SEMA4A/SEMA6D,2
GO:0016049,cell growth,9/157,496/18888,0.0230247157306676,0.305181256935247,0.281983290123141,ALCAM/FRZB/LIMK1/OLFM1/PRDM11/RIMS1/SEMA4A/SEMA6D/SFRP1,9
GO:0002377,immunoglobulin production,5/157,194/18888,0.0231425903345221,0.305181256935247,0.281983290123141,CD22/EXO1/IGKV2D-28/IL13RA2/NSD2,5
GO:0050864,regulation of B cell activation,4/157,130/18888,0.0232951217342961,0.305181256935247,0.281983290123141,CD22/NSD2/SFRP1/TNFRSF13C,4
GO:0009064,glutamine family amino acid metabolic process,3/157,74/18888,0.0237673523214207,0.305181256935247,0.281983290123141,ASRGL1/FAH/NOS2,3
GO:0001558,regulation of cell growth,8/157,418/18888,0.0237696814978834,0.305181256935247,0.281983290123141,FRZB/LIMK1/OLFM1/PRDM11/RIMS1/SEMA4A/SEMA6D/SFRP1,8
GO:0007127,meiosis I,4/157,131/18888,0.0238781078137886,0.305181256935247,0.281983290123141,BRCA2/ESPL1/HSPA2/SHOC1,4
GO:0038127,ERBB signaling pathway,4/157,131/18888,0.0238781078137886,0.305181256935247,0.281983290123141,ADRA2A/GRB7/PIGR/REPS2,4
GO:0003209,cardiac atrium morphogenesis,2/157,29/18888,0.0240667300060413,0.305181256935247,0.281983290123141,NOG/NSD2,2
GO:0007263,nitric oxide mediated signal transduction,2/157,29/18888,0.0240667300060413,0.305181256935247,0.281983290123141,CBS/NOS2,2
GO:0042403,thyroid hormone metabolic process,2/157,29/18888,0.0240667300060413,0.305181256935247,0.281983290123141,CPQ/DIO2,2
GO:0050951,sensory perception of temperature stimulus,2/157,29/18888,0.0240667300060413,0.305181256935247,0.281983290123141,ADRA2A/TRPM8,2
GO:0030323,respiratory tube development,5/157,197/18888,0.0245250581795159,0.308841907703668,0.285365681158676,CEBPA/CLDN18/NOG/SFTPD/TULP3,5
GO:0002637,regulation of immunoglobulin production,3/157,75/18888,0.0246104410350156,0.308841907703668,0.285365681158676,CD22/IL13RA2/NSD2,3
GO:0043032,positive regulation of macrophage activation,2/157,30/18888,0.0256472088722543,0.320193504580412,0.295854400772722,CEBPA/IL1RL1,2
GO:0045669,positive regulation of osteoblast differentiation,3/157,77/18888,0.0263446301457225,0.327213816476615,0.30234107254956,BMPR1B/CEBPA/RUNX2,3
GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,2/157,31/18888,0.0272687485957111,0.328958684555345,0.303953306690714,CLIC2/TMEM38A,2
GO:0031646,positive regulation of nervous system process,2/157,31/18888,0.0272687485957111,0.328958684555345,0.303953306690714,EGR2/RIMS1,2
GO:0051491,positive regulation of filopodium assembly,2/157,31/18888,0.0272687485957111,0.328958684555345,0.303953306690714,MIEN1/PIK3R1,2
GO:0150117,positive regulation of cell-substrate junction organization,2/157,31/18888,0.0272687485957111,0.328958684555345,0.303953306690714,PIK3R1/SFRP1,2
GO:0048469,cell maturation,5/157,205/18888,0.0284682487273294,0.328958684555345,0.303953306690714,BRCA2/CEBPA/GLDN/HEATR3/RUNX2,5
GO:0061982,meiosis I cell cycle process,4/157,139/18888,0.0288607124715089,0.328958684555345,0.303953306690714,BRCA2/ESPL1/HSPA2/SHOC1,4
GO:0007611,learning or memory,6/157,278/18888,0.0288804638395674,0.328958684555345,0.303953306690714,EGR2/NLGN4X/NOG/PDE1B/SNAP25/TACR2,6
GO:0042113,B cell activation,6/157,278/18888,0.0288804638395674,0.328958684555345,0.303953306690714,CD22/EXO1/NSD2/PIK3R1/SFRP1/TNFRSF13C,6
GO:0001958,endochondral ossification,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,CBS/RUNX2,2
GO:0009072,aromatic amino acid metabolic process,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,FAH/HAAO,2
GO:0035774,positive regulation of insulin secretion involved in cellular response to glucose stimulus,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,GPR68/SYBU,2
GO:0036075,replacement ossification,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,CBS/RUNX2,2
GO:0045879,negative regulation of smoothened signaling pathway,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,RUNX2/TULP3,2
GO:0051642,centrosome localization,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,GPSM2/PKHD1,2
GO:0061036,positive regulation of cartilage development,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,BMPR1B/RUNX2,2
GO:0061037,negative regulation of cartilage development,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,FRZB/NOG,2
GO:0061842,microtubule organizing center localization,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,GPSM2/PKHD1,2
GO:1901020,negative regulation of calcium ion transmembrane transporter activity,2/157,32/18888,0.0289305666882863,0.328958684555345,0.303953306690714,ADRA2A/CLIC2,2
GO:0014032,neural crest cell development,3/157,80/18888,0.0290657136642625,0.328958684555345,0.303953306690714,NRTN/SEMA4A/SEMA6D,3
GO:0008203,cholesterol metabolic process,4/157,141/18888,0.0301956886482136,0.337229269287954,0.311595213397449,CEBPA/CUBN/CYP7B1/SULT2B1,4
GO:0030099,myeloid cell differentiation,8/157,439/18888,0.030581514541932,0.337229269287954,0.311595213397449,CEBPA/CLDN18/GPR68/HEATR3/IL1RL1/PDE1B/PIK3R1/SFRP1,8
GO:0051216,cartilage development,5/157,209/18888,0.0305822213529138,0.337229269287954,0.311595213397449,BMPR1B/CBS/FRZB/NOG/RUNX2,5
GO:0002063,chondrocyte development,2/157,33/18888,0.0306318906867671,0.337229269287954,0.311595213397449,BMPR1B/RUNX2,2
GO:0035115,embryonic forelimb morphogenesis,2/157,33/18888,0.0306318906867671,0.337229269287954,0.311595213397449,HOXD9/RUNX2,2
GO:0043171,peptide catabolic process,2/157,33/18888,0.0306318906867671,0.337229269287954,0.311595213397449,ANPEP/CPQ,2
GO:0046928,regulation of neurotransmitter secretion,3/157,82/18888,0.0309593806016631,0.339292397363022,0.313501515404314,RIMS1/SNCAIP/TACR2,3
GO:0048841,regulation of axon extension involved in axon guidance,2/157,34/18888,0.0323719580420152,0.352713482253344,0.325902413521061,SEMA4A/SEMA6D,2
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,3/157,84/18888,0.0329164661962264,0.352713482253344,0.325902413521061,BMPR1B/PIK3R1/SFRP1,3
GO:0007266,Rho protein signal transduction,4/157,145/18888,0.0329738093503239,0.352713482253344,0.325902413521061,ADRA2A/C15orf62/LIMK1/SYNJ2BP,4
GO:0060048,cardiac muscle contraction,4/157,145/18888,0.0329738093503239,0.352713482253344,0.325902413521061,CLIC2/MYL3/TMEM38A/TNNI2,4
GO:0061448,connective tissue development,6/157,288/18888,0.0334757715863838,0.352713482253344,0.325902413521061,BMPR1B/CBS/FRZB/HSD17B1/NOG/RUNX2,6
GO:0061053,somite development,3/157,85/18888,0.0339187035601315,0.352713482253344,0.325902413521061,FRZB/NOG/SFRP1,3
GO:0031032,actomyosin structure organization,5/157,215/18888,0.0339343348190218,0.352713482253344,0.325902413521061,LIMK1/MYOM1/PHACTR1/PIK3R1/SFRP1,5
GO:0000132,establishment of mitotic spindle orientation,2/157,35/18888,0.0341500160092606,0.352713482253344,0.325902413521061,GPSM2/PKHD1,2
GO:0030224,monocyte differentiation,2/157,35/18888,0.0341500160092606,0.352713482253344,0.325902413521061,GPR68/PDE1B,2
GO:0099171,presynaptic modulation of chemical synaptic transmission,2/157,35/18888,0.0341500160092606,0.352713482253344,0.325902413521061,ADRA2A/NOG,2
GO:0048732,gland development,8/157,449/18888,0.0342557333979317,0.352713482253344,0.325902413521061,BRCA2/CEBPA/CYP7B1/FRZB/HOXD9/NOG/ONECUT2/SFRP1,8
GO:0050714,positive regulation of protein secretion,4/157,147/18888,0.0344171637789388,0.352713482253344,0.325902413521061,GPR68/MYOM1/SNAP25/SYBU,4
GO:0170039,proteinogenic amino acid metabolic process,4/157,147/18888,0.0344171637789388,0.352713482253344,0.325902413521061,ASRGL1/CBS/FAH/NOS2,4
GO:1901605,alpha-amino acid metabolic process,5/157,216/18888,0.0345143540824592,0.352713482253344,0.325902413521061,ASRGL1/CBS/FAH/HAAO/NOS2,5
GO:0032024,positive regulation of insulin secretion,3/157,86/18888,0.0349366849197803,0.352713482253344,0.325902413521061,GPR68/SNAP25/SYBU,3
GO:0048864,stem cell development,3/157,86/18888,0.0349366849197803,0.352713482253344,0.325902413521061,NRTN/SEMA4A/SEMA6D,3
GO:0051321,meiotic cell cycle,6/157,291/18888,0.0349417385271383,0.352713482253344,0.325902413521061,ANAPC13/BRCA2/ESPL1/EXO1/HSPA2/SHOC1,6
GO:0071805,potassium ion transmembrane transport,5/157,217/18888,0.0351005063526109,0.352713482253344,0.325902413521061,KCNK12/SLC1A3/SLC9A3/SNAP25/TMEM38A,5
GO:0001580,detection of chemical stimulus involved in sensory perception of bitter taste,2/157,36/18888,0.0359653215395154,0.352713482253344,0.325902413521061,CST2/PIGR,2
GO:0006882,intracellular zinc ion homeostasis,2/157,36/18888,0.0359653215395154,0.352713482253344,0.325902413521061,MT1F/SLC30A7,2
GO:0014808,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,2/157,36/18888,0.0359653215395154,0.352713482253344,0.325902413521061,CLIC2/TMEM38A,2
GO:0045920,negative regulation of exocytosis,2/157,36/18888,0.0359653215395154,0.352713482253344,0.325902413521061,ADRA2A/IL13RA2,2
GO:0060317,cardiac epithelial to mesenchymal transition,2/157,36/18888,0.0359653215395154,0.352713482253344,0.325902413521061,NOG/OLFM1,2
GO:0070633,transepithelial transport,2/157,36/18888,0.0359653215395154,0.352713482253344,0.325902413521061,CLDN18/SLC1A3,2
GO:0071425,hematopoietic stem cell proliferation,2/157,36/18888,0.0359653215395154,0.352713482253344,0.325902413521061,BRCA2/CEBPA,2
GO:0008306,associative learning,3/157,87/18888,0.0359703675130372,0.352713482253344,0.325902413521061,NOG/PDE1B/SNAP25,3
GO:0050679,positive regulation of epithelial cell proliferation,5/157,219/18888,0.0362912618086281,0.354425145566521,0.32748396691487,CYP7B1/NOG/PKHD1/RUNX2/SFRP1,5
GO:0035107,appendage morphogenesis,4/157,150/18888,0.0366502923411674,0.355012077204729,0.328026283687797,HOXD9/NOG/RUNX2/TULP3,4
GO:0035108,limb morphogenesis,4/157,150/18888,0.0366502923411674,0.355012077204729,0.328026283687797,HOXD9/NOG/RUNX2/TULP3,4
GO:0060541,respiratory system development,5/157,220/18888,0.0368958897906528,0.355012077204729,0.328026283687797,CEBPA/CLDN18/NOG/SFTPD/TULP3,5
GO:0061515,myeloid cell development,3/157,88/18888,0.0370197058777249,0.355012077204729,0.328026283687797,CLDN18/GPR68/HEATR3,3
GO:0001736,establishment of planar polarity,2/157,37/18888,0.0378171411720974,0.355012077204729,0.328026283687797,PKHD1/SFRP1,2
GO:0003230,cardiac atrium development,2/157,37/18888,0.0378171411720974,0.355012077204729,0.328026283687797,NOG/NSD2,2
GO:0007164,establishment of tissue polarity,2/157,37/18888,0.0378171411720974,0.355012077204729,0.328026283687797,PKHD1/SFRP1,2
GO:0033144,negative regulation of intracellular steroid hormone receptor signaling pathway,2/157,37/18888,0.0378171411720974,0.355012077204729,0.328026283687797,CYP7B1/SFRP1,2
GO:0070873,regulation of glycogen metabolic process,2/157,37/18888,0.0378171411720974,0.355012077204729,0.328026283687797,POMC/PPP1R3F,2
GO:1903514,release of sequestered calcium ion into cytosol by endoplasmic reticulum,2/157,37/18888,0.0378171411720974,0.355012077204729,0.328026283687797,CLIC2/TMEM38A,2
GO:0001843,neural tube closure,3/157,89/18888,0.0380846519174461,0.355703564525924,0.328665208475863,NOG/SFRP1/TULP3,3
GO:1902652,secondary alcohol metabolic process,4/157,152/18888,0.0381845279837903,0.355703564525924,0.328665208475863,CEBPA/CUBN/CYP7B1/SULT2B1,4
GO:0060606,tube closure,3/157,90/18888,0.0391651549663632,0.36344063344265,0.335814153895899,NOG/SFRP1/TULP3,3
GO:0045055,regulated exocytosis,5/157,225/18888,0.0400119867375655,0.369881801062533,0.341765704315244,ADRA2A/IL13RA2/RIMS1/SNAP25/SV2A,5
GO:0016125,sterol metabolic process,4/157,155/18888,0.0405542012628829,0.373110834793321,0.34474928713573,CEBPA/CUBN/CYP7B1/SULT2B1,4
GO:0006874,intracellular calcium ion homeostasis,6/157,302/18888,0.0406693890939045,0.373110834793321,0.34474928713573,CALB2/CLIC2/PKHD1/SV2A/TMEM38A/TRPM8,6
GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,2/157,39/18888,0.0416274362058635,0.377609177867421,0.34890569435705,NOG/RUNX2,2
GO:0050892,intestinal absorption,2/157,39/18888,0.0416274362058635,0.377609177867421,0.34890569435705,ADRA2A/CEL,2
GO:0071312,cellular response to alkaloid,2/157,39/18888,0.0416274362058635,0.377609177867421,0.34890569435705,SLC1A3/TMEM38A,2
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,7/157,385/18888,0.0421868588313496,0.381255866005704,0.352275184114097,CLU/EXO1/IL13RA2/IL1RL1/KLRC1/NSD2/SEMA4A,7
GO:0030902,hindbrain development,4/157,158/18888,0.0430059057037942,0.385766591763251,0.356443032764862,CBS/EGR2/NLGN4X/NOG,4
GO:0008210,estrogen metabolic process,2/157,40/18888,0.0435844916752404,0.385766591763251,0.356443032764862,HSD17B1/HSD17B2,2
GO:0044060,regulation of endocrine process,2/157,40/18888,0.0435844916752404,0.385766591763251,0.356443032764862,POMC/TACR2,2
GO:0046676,negative regulation of insulin secretion,2/157,40/18888,0.0435844916752404,0.385766591763251,0.356443032764862,ADRA2A/SFRP1,2
GO:0051492,regulation of stress fiber assembly,3/157,94/18888,0.043641637548774,0.385766591763251,0.356443032764862,LIMK1/PIK3R1/SFRP1,3
GO:0051952,regulation of amine transport,3/157,94/18888,0.043641637548774,0.385766591763251,0.356443032764862,ADRA2A/SV2A/TACR2,3
GO:0051656,establishment of organelle localization,8/157,472/18888,0.0438202712607224,0.385937079976253,0.356600561532233,ESPL1/GPSM2/IL13RA2/NEFH/PKHD1/SNAP25/SYBU/WDR11,8
GO:0019722,calcium-mediated signaling,5/157,232/18888,0.0446365567762252,0.391701958376875,0.361927230000972,CD22/CLIC2/POMC/TMEM38A/TRPM8,5
GO:0014020,primary neural tube formation,3/157,95/18888,0.0447990801320839,0.391708924476199,0.361933666581077,NOG/SFRP1/TULP3,3
GO:0033260,nuclear DNA replication,2/157,41/18888,0.0455752211759731,0.394225663172168,0.364259098571876,BRCA2/MCM4,2
GO:0035136,forelimb morphogenesis,2/157,41/18888,0.0455752211759731,0.394225663172168,0.364259098571876,HOXD9/RUNX2,2
GO:0050913,sensory perception of bitter taste,2/157,41/18888,0.0455752211759731,0.394225663172168,0.364259098571876,CST2/PIGR,2
GO:0015850,organic hydroxy compound transport,6/157,311/18888,0.0457745470522419,0.394540757866655,0.364550241742148,ABCA8/ADRA2A/CEL/CLU/MAOB/POMC,6
GO:0016079,synaptic vesicle exocytosis,3/157,96/18888,0.0459717252713341,0.394835172365855,0.364822276695992,RIMS1/SNAP25/SV2A,3
GO:0021675,nerve development,3/157,97/18888,0.0471595060438864,0.400293843413718,0.369866013776159,EGR2/NRTN/SLC1A3,3
GO:0051017,actin filament bundle assembly,4/157,163/18888,0.0472742817411089,0.400293843413718,0.369866013776159,LIMK1/PHACTR1/PIK3R1/SFRP1,4
GO:0170033,L-amino acid metabolic process,4/157,163/18888,0.0472742817411089,0.400293843413718,0.369866013776159,ASRGL1/CBS/FAH/NOS2,4
GO:0009409,response to cold,2/157,42/18888,0.0475989376148434,0.400293843413718,0.369866013776159,HSPA2/TRPM8,2
GO:0050912,detection of chemical stimulus involved in sensory perception of taste,2/157,42/18888,0.0475989376148434,0.400293843413718,0.369866013776159,CST2/PIGR,2
GO:0051294,establishment of spindle orientation,2/157,42/18888,0.0475989376148434,0.400293843413718,0.369866013776159,GPSM2/PKHD1,2
GO:0006942,regulation of striated muscle contraction,3/157,98/18888,0.0483623534400539,0.404896347552985,0.374118664391171,CLIC2/MYL3/TMEM38A,3
GO:0050673,epithelial cell proliferation,8/157,482/18888,0.0484805701033714,0.404896347552985,0.374118664391171,BRCA2/CLDN18/CYP7B1/NOG/PKHD1/RUNX2/SFRP1/SYNJ2BP,8
GO:0072593,reactive oxygen species metabolic process,5/157,238/18888,0.0488455399509957,0.406542603990761,0.375639782730392,ADGRB1/CBS/MAOB/NOS2/SFTPD,5
GO:0051588,regulation of neurotransmitter transport,3/157,99/18888,0.049580196419114,0.407675661215269,0.376686712044705,RIMS1/SNCAIP/TACR2,3
GO:0060349,bone morphogenesis,3/157,99/18888,0.049580196419114,0.407675661215269,0.376686712044705,BMPR1B/CBS/RUNX2,3
GO:0060412,ventricular septum morphogenesis,2/157,43/18888,0.0496549628647829,0.407675661215269,0.376686712044705,NOG/NSD2,2
GO:0070296,sarcoplasmic reticulum calcium ion transport,2/157,43/18888,0.0496549628647829,0.407675661215269,0.376686712044705,CLIC2/TMEM38A,2
GO:0001678,intracellular glucose homeostasis,4/157,166/18888,0.0499444274189314,0.408666902731931,0.377602605592632,ADRA2A/GPR68/PIK3R1/SYBU,4
